Riskpilot← Back to searchSign inGet full accessAbbott Rapid Diagnostics AB
ABActiveOrg 5565794301Knarrarnäsgatan 7Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19995-9 employees
Revenue 2024
SEK 74,5M
-19% vs 2023
EBITDA margin
11.1%
+7% vs 2023
Equity ratio
15.8%
Financial strength
Net profit 2024
SEK 2,2M
-32% vs 2023
| Revenue | SEK 74,5M | -19% |
| EBITDA | SEK 8,3M | +7% |
| Net profit | SEK 2,2M | -32% |
| Total assets | SEK 119,2M | +38% |
| Equity | SEK 18,8M | +13% |
| Employees | — | — |
Legal name
Abbott Rapid Diagnostics AB
Org number
5565794301
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19 november 1999
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall ha till föremål för sin verksamhet att, direkt eller indirekt, bedriva handels- och distributionsverksamhet inom invitrodiagnosiska produkter och medicinsk tekniska produkter, samt annan därmed förenlig verksamhet.
Address
Knarrarnäsgatan 7
Phone
+46854481200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 124 190 | 220 731 | 172 698 | 92 438 | 74 499 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 702 | 8 396 | 7 600 | 7 702 | 8 251 |
| Depreciation & amort. | −2 511 | −1 687 | −2 458 | −4 041 | −4 735 |
| EBIT | 4 191 | 6 709 | 5 142 | 3 661 | 3 516 |
| Net financials | −933 | −547 | −406 | −1 348 | −1 923 |
| Profit before tax | 2 202 | 5 965 | 5 059 | 3 861 | 2 599 |
| Tax | −938 | −1 220 | −749 | −679 | −442 |
| Net profit | 1 264 | 4 745 | 4 310 | 3 182 | 2 157 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 108 821 | 73 543 | 82 449 | 86 165 | 119 202 |
| Equity | 4 413 | 9 158 | 13 468 | 16 650 | 18 807 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 94 131 | 53 913 | 58 821 | 60 903 | 92 745 |
| Total debt | 94 131 | 53 913 | 58 821 | 60 903 | 92 745 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20202024
Equity ratio
15.8%
This company
38.2%
Market median
-59% vs market
20202024
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20202024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20202024
Debt / equity
5.34×
This company
0.62×
Market median
-761% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ME Chief Auditor | Chief Auditor | 2024 |
BL Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (5) | ||
AL Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
IM Chief Auditor | Chief Auditor | 2022 – 2024 |
PC Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
YH Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
JE Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ST. JUDE MEDICAL LUXEMBOURG
Abbott Rapid Diagnostics AB Board members of Abbott Rapid Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Lennart Gottlieb Juhlin | Chief Executive Officer | 0 companies |
| Maria Erzsébet Magdalena Lennmark | Chief Auditor | 0 companies |
| Ida Maria Brandt | Chief Auditor | 0 companies |
| Patrik Collby | Chief Executive Officer | 0 companies |
| Yvon Holmlund | Chief Executive Officer | 0 companies |
| Johan Erik Sylvén | Chief Auditor | 0 companies |
| Berit Landsend-Holo | Chief Executive Officer | 0 companies |
| Fredrik Björn Anders Björnulfson | Chairman | 0 companies |
| Thor Harald Kløver | Board of Directors | 0 companies |
| Petter Aspaas | Chairman | 0 companies |
| Oddvar Arne Vanberg | Board of Directors | 0 companies |